The team of three advisors have started a firm called T6 Wealth Management, which will operate out of Morgan Stanley's new ...
Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to InvestingPro data, the stock currently trades at $6.40, with analyst ...
Stifel Raises Quarterly Common Stock Cash Dividend by 10% and Declares Preferred Stock Cash Dividend
LOUIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE ... The Company’s Series B Preferred Stock trades on the New York Stock Exchange under the symbol “SF PrB”, the Company’s Series C ...
Research analysts at Stifel Canada issued their Q4 2024 earnings per share estimates for Osisko Gold Royalties in a research ...
Ron Kruszewski, Stifel's chairman and CEO, told financial analysts that its investment banking franchise is well-positioned ...
Stifel Financial Corp. announced a cash dividend ... The Company’s Series B Preferred Stock trades on the New York Stock Exchange under the symbol “SF PrB”, the Company’s Series C ...
(RTTNews) - Stifel Financial Corp. (SF ... Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback